Percutaneous Pulmonary Valve Implantation In Native Right Ventricular Outflow Tract Using Myval™ Without Pre‐Stenting
In conclusion, the 30.5 and 32 mm MyVal™ valves have significant potential for treating patients with large native RVOTs, providing a safe and effective alternative to traditional surgical approaches and existing percutaneous options.
Authors
- Raul Ivo Rossi Filho
- João Vitor Slaviero (ORCID: https://orcid.org/0000-0003-4198-2621)
- Francisco Chamié (ORCID: https://orcid.org/0000-0002-6004-4959)
- João Henrique Aramayo Rossi (ORCID: https://orcid.org/0000-0003-2894-6626)
- Ênio Eduardo Guérios (ORCID: https://orcid.org/0000-0002-2434-2561)
- Germana Coimbra
- Vanêssa Gomes Fraga
- João Luiz Mânica (ORCID: https://orcid.org/0000-0002-5714-9880)
- Santiago Raul Arrieta
- Fábio Vieira Caovilla
- Marcelo Silva Ribeiro (ORCID: https://orcid.org/0000-0002-0532-2776)
- Carlo Benatti Pilla
- P. R. O. Thomé
- Carlos Augusto Cardoso Pedra (ORCID: https://orcid.org/0009-0004-7014-690X)
Institutions
- Universidade de São Paulo (BR)
- Hospital Israelita Albert Einstein (BR)
- Hospital Moinhos de Vento (BR)
- Methodist University of Piracicaba (BR)
- Fundação Universitária de Cardiologia (BR)
- Santa Casa de Misericórdia de Marília (BR)
- Hospital de Clínicas Universidade Federal do Paraná (BR)
- Hospital do Coração (BR)
- Laboratório Interinstitucional de e-Astronomia (BR)
- Instituto Dante Pazzanese de Cardiologia (BR)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/hsr2.70598
- Primary Topic
- Congenital Heart Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00